Robert Andrew Berman
CIK: 0001258360
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVNO
enVVeno Medical Corp
DirectorOfficer
Discretionary Trading P&L
Holdings
About BERMAN ROBERT ANDREW
BERMAN ROBERT ANDREW (SEC CIK 0001258360) files insider reports with the SEC as Chief Executive Officer of enVVeno Medical Corp (NVNO).
Signal8 holds 3 ownership filings by BERMAN ROBERT ANDREW, all Form 4s, filed between Dec 19, 2024 and Dec 18, 2025. Those filings report 3 transactions, from Dec 18, 2024 to Dec 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on BERMAN ROBERT ANDREW's filings is in IRVINE, CA.
Recent filings by BERMAN ROBERT ANDREW
Other insiders filing for enVVeno Medical Corp (NVNO)
- Duhay Francis, Director
- Alavi Hamed, Chief Technology Officer
- Glickman Marc H., SVP & Chief Medical Officer
- Gray Robert, Director
- Jenusaitis Matthew, Director
- Shrivastava Sanjay, Director